239 related articles for article (PubMed ID: 36496109)
1. Chalcones: Promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer.
WalyEldeen AA; Sabet S; El-Shorbagy HM; Abdelhamid IA; Ibrahim SA
Chem Biol Interact; 2023 Jan; 369():110297. PubMed ID: 36496109
[TBL] [Abstract][Full Text] [Related]
2. Chalcones against the hallmarks of cancer: a mini-review.
de Souza PS; Bibá GCC; Melo EDDN; Muzitano MF
Nat Prod Res; 2022 Sep; 36(18):4809-4826. PubMed ID: 34865580
[TBL] [Abstract][Full Text] [Related]
3. Chalcone Derivatives: Role in Anticancer Therapy.
Ouyang Y; Li J; Chen X; Fu X; Sun S; Wu Q
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34208562
[TBL] [Abstract][Full Text] [Related]
4. Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structure-activity relationship.
Gao F; Huang G; Xiao J
Med Res Rev; 2020 Sep; 40(5):2049-2084. PubMed ID: 32525247
[TBL] [Abstract][Full Text] [Related]
5. Natural Chalcones and Their Derivatives Target the Tumor Microenvironment in Colon Cancer.
Malla RR; Siragam S; Dadi V; Seetini B
Crit Rev Immunol; 2022; 42(6):27-39. PubMed ID: 37082949
[TBL] [Abstract][Full Text] [Related]
6. Chalcone Scaffolds as Anticancer Drugs: A Review on Molecular Insight in Action of Mechanisms and Anticancer Properties.
Shukla S; Sood AK; Goyal K; Singh A; Sharma V; Guliya N; Gulati S; Kumar S
Anticancer Agents Med Chem; 2021; 21(13):1650-1670. PubMed ID: 33238850
[TBL] [Abstract][Full Text] [Related]
7. Current scenario of chalcone hybrids with antibreast cancer therapeutic applications.
Wang H; Zhu J; Zhang Q; Tang J; Huang X
Arch Pharm (Weinheim); 2024 May; 357(5):e2300640. PubMed ID: 38227398
[TBL] [Abstract][Full Text] [Related]
8. Anticancer Activity of Natural and Synthetic Chalcones.
Constantinescu T; Lungu CN
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768736
[TBL] [Abstract][Full Text] [Related]
9. Advances in chalcones with anticancer activities.
Karthikeyan C; Moorthy NS; Ramasamy S; Vanam U; Manivannan E; Karunagaran D; Trivedi P
Recent Pat Anticancer Drug Discov; 2015; 10(1):97-115. PubMed ID: 25138130
[TBL] [Abstract][Full Text] [Related]
10. Recent Progresses in Chalcone Derivatives as Potential Anticancer Agents.
Yang J; Lv J; Cheng S; Jing T; Meng T; Huo D; Ma X; Wen R
Anticancer Agents Med Chem; 2023; 23(11):1265-1283. PubMed ID: 36825723
[TBL] [Abstract][Full Text] [Related]
11. Chalcones derivatives acting as cell cycle blockers: potential anti cancer drugs?
Boumendjel A; Ronot X; Boutonnat J
Curr Drug Targets; 2009 Apr; 10(4):363-71. PubMed ID: 19355861
[TBL] [Abstract][Full Text] [Related]
12. Heterocyclic chalcone analogues as potential anticancer agents.
Sharma V; Kumar V; Kumar P
Anticancer Agents Med Chem; 2013 Mar; 13(3):422-32. PubMed ID: 22721390
[TBL] [Abstract][Full Text] [Related]
13. Chalcones and Gastrointestinal Cancers: Experimental Evidence.
Michalkova R; Kello M; Cizmarikova M; Bardelcikova A; Mirossay L; Mojzis J
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983038
[TBL] [Abstract][Full Text] [Related]
14. Chalcone Derivatives and their Activities against Drug-resistant Cancers: An Overview.
Xiao J; Gao M; Diao Q; Gao F
Curr Top Med Chem; 2021; 21(5):348-362. PubMed ID: 33092509
[TBL] [Abstract][Full Text] [Related]
15. Targeting Ovarian Cancer with Chalcone Derivatives: Cytotoxicity and Apoptosis Induction in HGSOC Cells.
Merve Aydin E; Canıtez İS; Colombo E; Princiotto S; Passarella D; Dallavalle S; Christodoulou MS; Durmaz Şahin I
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067507
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3',4',5'-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities.
Srinivasan B; Johnson TE; Lad R; Xing C
J Med Chem; 2009 Nov; 52(22):7228-35. PubMed ID: 19883086
[TBL] [Abstract][Full Text] [Related]
17. Natural and Synthetic Chalcones: Potential Impact on Breast Cancer.
Dadi V; Malla RR; Siragam S
Crit Rev Oncog; 2023; 28(4):27-40. PubMed ID: 38050979
[TBL] [Abstract][Full Text] [Related]
18. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic Effect of Flavonoids and Chalcones: An Update.
Mirossay L; Varinská L; Mojžiš J
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29271940
[TBL] [Abstract][Full Text] [Related]
20. Anticancer Potential of Natural Chalcones: In Vitro and In Vivo Evidence.
Michalkova R; Mirossay L; Kello M; Mojzisova G; Baloghova J; Podracka A; Mojzis J
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]